Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HAGEMEISTER, FREDRICK B
One or more keywords matched the following items that are connected to HAGEMEISTER, FREDRICK B
Item TypeName
Academic Article Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Concept Ifosfamide
Academic Article Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Academic Article Results of MIME salvage regimen for recurrent or refractory lymphoma.
Academic Article IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Academic Article Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Academic Article MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
Academic Article Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Academic Article Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Academic Article Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Academic Article Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Academic Article A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Academic Article Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Academic Article The role of ifosfamide in the treatment of lymphomas.
Academic Article A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Academic Article Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Academic Article Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Search Criteria
  • Ifosfamide